VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,530 | -10.6% | 94 | 0.0% | 0.00% | – |
| Q2 2023 | $2,830 | -68.0% | 94 | -65.7% | 0.00% | – |
| Q1 2023 | $8,856 | +52.4% | 274 | +35.0% | 0.00% | – |
| Q4 2022 | $5,811 | -73.6% | 203 | -77.9% | 0.00% | -100.0% |
| Q3 2022 | $22,000 | -99.2% | 918 | -99.1% | 0.00% | -98.7% |
| Q2 2022 | $2,720,000 | -20.0% | 99,359 | +12.1% | 0.08% | -9.2% |
| Q1 2022 | $3,399,000 | -11.8% | 88,640 | -26.3% | 0.09% | -11.2% |
| Q4 2021 | $3,854,000 | +5.5% | 120,331 | -2.9% | 0.10% | -3.9% |
| Q3 2021 | $3,653,000 | -15.0% | 123,943 | -2.0% | 0.10% | -19.0% |
| Q2 2021 | $4,297,000 | +1.2% | 126,459 | -3.2% | 0.13% | -8.7% |
| Q1 2021 | $4,244,000 | +32546.2% | 130,581 | +38419.5% | 0.14% | +13700.0% |
| Q4 2020 | $13,000 | 0.0% | 339 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -99.7% | 339 | -99.7% | 0.00% | -99.5% |
| Q2 2020 | $4,617,000 | +230750.0% | 125,875 | +144583.9% | 0.21% | – |
| Q1 2020 | $2,000 | -99.5% | 87 | -99.3% | 0.00% | -100.0% |
| Q4 2019 | $391,000 | +32.1% | 13,366 | +20.7% | 0.02% | +21.4% |
| Q3 2019 | $296,000 | -69.8% | 11,071 | -71.2% | 0.01% | -72.0% |
| Q2 2019 | $981,000 | +23.1% | 38,384 | +8.0% | 0.05% | -3.8% |
| Q1 2019 | $797,000 | +75.2% | 35,531 | +64.5% | 0.05% | +92.6% |
| Q4 2018 | $455,000 | +8.3% | 21,593 | -4.8% | 0.03% | +22.7% |
| Q3 2018 | $420,000 | -22.9% | 22,686 | -7.1% | 0.02% | -24.1% |
| Q2 2018 | $545,000 | 0.0% | 24,431 | -1.5% | 0.03% | -3.3% |
| Q1 2018 | $545,000 | -9.2% | 24,804 | -3.9% | 0.03% | -14.3% |
| Q4 2017 | $600,000 | +6.8% | 25,823 | +5.5% | 0.04% | -2.8% |
| Q3 2017 | $562,000 | +13.5% | 24,466 | +9.2% | 0.04% | +2.9% |
| Q2 2017 | $495,000 | -13.9% | 22,401 | -11.2% | 0.04% | -20.5% |
| Q1 2017 | $575,000 | +71.6% | 25,217 | +57.4% | 0.04% | +51.7% |
| Q4 2016 | $335,000 | -5.9% | 16,021 | +19.0% | 0.03% | -17.1% |
| Q3 2016 | $356,000 | +92.4% | 13,462 | +101.6% | 0.04% | +75.0% |
| Q2 2016 | $185,000 | – | 6,677 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |